Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07574229
Support System Design for Adolescent Scoliosis Orthosis WearShanghai Jiao Tong University School of MedicineRecruitingNot Applicable
NCT07574229Recruiting
Not Applicable
Support System Design for Adolescent Scoliosis Orthosis WearShanghai Jiao Tong Univer...
NCT07573709
Functional and Affective Effects of a Brief tDCS Intervention in Fibromyalgia and Chronic Fatigue SyndromeHospital DonostiaTerminatedNot Applicable
NCT07573709Terminated
Not Applicable
Functional and Affective Effects of a Brief tDCS Intervention in Fibromyalgia an...Hospital Donostia
NCT07572084
Romiplostim N01 in Chemoradiotherapy-induced Aplastic AnemiaPeking Union Medical College HospitalNot Yet RecruitingPhase 2
NCT07572084Not Yet Recruiting
Phase 2
Romiplostim N01 in Chemoradiotherapy-induced Aplastic AnemiaPeking Union Medical Coll...
NCT07573488
Sleep, Stress and Migraine - an Observational and Training StudySusanne WegenerRecruitingNot Applicable
NCT07573488Recruiting
Not Applicable
Sleep, Stress and Migraine - an Observational and Training StudySusanne Wegener
NCT07572903
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's DiseaseThe First Affiliated Hospital of Anhui Medical UniversityNot Yet RecruitingNot Applicable
NCT07572903Not Yet Recruiting
Not Applicable
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms o...The First Affiliated Hosp...
NCT07573982
Ultrasonic Debris Clearance to Promote Brain ResilienceStanford UniversityNot Yet RecruitingNot Applicable
NCT07573982Not Yet Recruiting
Not Applicable
Ultrasonic Debris Clearance to Promote Brain ResilienceStanford University
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07573345
Pain and Upper Extremity Function in Smartphone and Digital Game AddictionIstinye UniversityRecruiting
NCT07573345Recruiting
—
Pain and Upper Extremity Function in Smartphone and Digital Game AddictionIstinye University
NCT07572981
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving Hot Flashes in Menopausal WomenUniversity Hospital, ToulouseNot Yet RecruitingNot Applicable
NCT07572981Not Yet Recruiting
Not Applicable
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving H...University Hospital, Toul...
NCT07573566
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardiac ArrestKlinikum Klagenfurt am WörtherseeNot Yet RecruitingNot Applicable
NCT07573566Not Yet Recruiting
Not Applicable
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardia...Klinikum Klagenfurt am Wö...
NCT07572149
THE EFFECT OF FOOD SAFETY TRAINING ON EMPLOYEES' KNOWLEDGE, ATTITUDES, AND PRACTICES: A SOLOMON FOUR-GROUP EXPERIMENTKayseri UniversityCompletedNot Applicable
NCT07572149Completed
Not Applicable
THE EFFECT OF FOOD SAFETY TRAINING ON EMPLOYEES' KNOWLEDGE, ATTITUDES, AND PRACT...Kayseri University
NCT07572630
Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Task Demands and Spatial Attention (Expt 2.2)National Eye Institute (NEI)Enrolling By InvitationNot Applicable
NCT07572630Enrolling By Invitation
Not Applicable
Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Task D...National Eye Institute (N...
NCT07572370
Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Breast CancerRoyal College of Surgeons, IrelandRecruiting
NCT07572370Recruiting
—
Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Cur...Royal College of Surgeons...
NCT07573449
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPhase 1
NCT07573449Completed
Phase 1
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Si...Otsuka Pharmaceutical Dev...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07574359
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes in the Russian PopulationPirogov Russian National Research Medical UniversityRecruiting
NCT07574359Recruiting
—
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes...Pirogov Russian National...
NCT07574333
Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in Patients With Type 2 Diabetes Including ElderlyNational Medical Research Center for Therapy and Preventive MedicineRecruitingNot Applicable
NCT07574333Recruiting
Not Applicable
Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in...National Medical Research...
NCT07574255
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical ApplicationNational Taiwan University HospitalNot Yet Recruiting
NCT07574255Not Yet Recruiting
—
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical ApplicationNational Taiwan Universit...
Result Breakdown
Recruiting8 (40%)
Not yet recruiting8 (40%)
Completed2 (10%)
Terminated1 (5%)
Enrolling by invitation1 (5%)
not_applicable11 (55%)
Not Specified5 (25%)
Phase 22 (10%)
Phase 12 (10%)